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The present study was conducted to identify new target
immunogenic molecules from the larval stage of the cattle
tick, Boophilus annulatus (Acari: Ixodidae). Two specific
larval glycoproteins (GLPs) were isolated by two-step
affinity chromatography. The larval immunogens were
first purified with CNBr-Sepharose coupled to rabbit
anti-larval immunoglobulins, and the glycoproteins were
then purified with Con-A Sepharose. These glycoproteins
have molecular weights of approximately 32 and 15 kDa
with isoelectric points between 6.8 and 7.2. Antibodies
against the two GLPs, labeled I and II, were detected in
the anti-whole tick, -whole larval, and -gut antigens
through immunoblot analysis. These results suggest that
these GLPs are good immunogens and can be useful in the
vaccination of cattle against tick infestation.
Key words: Boophilus annulatus, glycoproteins, larvae, vac-
cination.
Introduction
Ticks are of great veterinary importance compared to
other ectoparasites. They consume large quantities of host
blood during their lengthy attachment period (7-14 days),
which may be extended depending on the tick species and
unique host association.
The bovine tick, Boophilus annulatus (B. annulatus), is a
bloodsucking ectoparasite that causes severe production
losses in the cattle industry. The average tick burden causes
an annual weight loss of 0.7 kg/tick. With the huge number
of ticks infesting cattle and other livestock animals, the
subsequent effect on beef production is a reduction of
hundreds of millions of kilograms annually. Camels, cattle,
and chickens are severely affected by ticks, because ticks
suck their blood, and may transmit serious pathogenic
microorganisms. The control of tick infestations and the
transmission of tick-borne diseases remain a challenge for
the cattle industry in many areas of the world. Conventional
methods used for the control of tick infestation to prevent
disease among livestock include the use of chemical toxic
acaricides, with partially successful results. However, this
treatment has certain implicit drawbacks, such as the
presence of residues in the milk and meat, as well as the
selection of chemical-resistant tick strains [16,28]. B.
microplus has developed resistance to a range of chemical
acaricides [1], which has stimulated the development of
alternative methods such as vaccination against ticks.
Alternative approaches for tick control, including the use
of natural host resistance and development of vaccines to
induce an immunological response against tick infestations,
have been conducted [21]. A major milestone in vaccine
development against the different parasites was the launch
of the first genetically-engineered E. coli-expressed Bm86
vaccine which is directed against the cattle tick, B.
microplus in Australia [27]. A similar recombinant vaccine
which is produced in the Pichia pastoris yeast, was
developed and commercialized in Cuba [5,7]. The effect of
both vaccines is not a direct killing of ticks, but a successive
reduction in numbers as a consequence of a reduction of
adult female tick fertility [14].
Development of immunization against the cattle tick, B.
annulatus, will present an alternative means by which to
control this ectoparasite. The use of several candidate
vaccines will reduce the number of acaricide treatments,
thus allowing the assumption that savings per animal
 /year
will increase over time. The candidate vaccine will control
the transmission of tick-borne diseases such as Babesia
bovis infections and anaplasmosis. The major effect of
vaccination is not only to kill the ticks currently infecting the
herd of cattle, but also to reduce the posterior contamination,
and thereby the parasite challenge in the next generation.
This vaccine will cause the recovery of bovine erythrocytes,
reduce clinical cases, increase milk production, and finally
increase meat production.
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Several Boophilus tick isolates such as Argentinean strain
A showed low susceptibility to vaccination with the well-
known commercial vaccines due to some genetic variations
[7]. Therefore, research should be continued in order to
purify and characterize new immunogenic molecules. In the
present study, we report the isolation and purification of two
candidate glycoproteins from the larval stage of the cattle
tick, B. annulatus. These glycoproteins may be useful for
the vaccination of cattle against tick infestation.
Materials and Methods
Ticks and larvae
Adult and nymphal ticks identified as B. annulatus were
collected from cattle during several visits to slaughterhouses
and field trips to the Matrouh, Gharbiya, and Qalyubia
Governorates. Ticks were picked up using pointed forceps.
To start different colonies, fully-engorged adults were left to
lay egg masses, which were maintained at the animal
facility. Ticks were kept under a 14 : 10 light to dark (L : D)
photoperiod at 25
oC and 93% relative humidity, according
to the procedure described by [17].
Whole tick, larval, and gut antigens
Whole tick and larval antigens of B. annulatus were
constructed according to the method of Ghosh et al. [9,10]. In
brief, laboratory-reared, clean, 5- to 6-day-old unfed ticks or
larvae were homogenized in cold 0.15 M phosphate-buffered
saline (PBS) and 1 mM disodium EDTA, pH 7.2, containing
cocktail protease inhibitors, and were then filtered, sonicated,
and centrifuged at 15,000 × g for 60 min at 4
oC. The
supernatant was designated as whole tick or larval antigen.
The protein concentrations of the antigens were estimated
according to the method of Bradford [3]. Gut antigens were
prepared according to the method of Das et al. [6]. In brief,
midguts from the partially-fed ticks were dissected out and
homogenized in extraction buffer, sonicated, and centrifuged.
Supernatants were then collected as gut antigen.
Preparation of rabbit anti-whole tick, larval, and gut
antigens
For raising anti-whole tick, larval, and gut antibodies of B.
annulatus, three separate male rabbits (~3 Kg) were
immunized by intramuscular injection with 100 µg of whole
tick, larval, or gut antigens. The antigens dissolved in 0.5 ml
of saline (0.9% NaCl) and mixed with an equal volume of
Freund’s complete adjuvant (Sigma, USA) were injected on
day 0. Rabbits were boosted by 50 µg of the same antigens
mixed with Freund’s incomplete adjuvant on day 14 by the
same route. Seven days after boosting, the rabbits were bled
from the marginal ear vein, the serum was pooled, and the
immunoglobulins were purified by affinity chromatography
using protein G-sepharose CL-4B according to the instructions
of the manufacturer.
Immunoaffinity chromatography
The purified immunoglobulins (IgGs) of the rabbit anti-
larval antigens were dialyzed against coupling buffer (0.1 M
NaHCO3, 0.5 M NaCl, pH 8.4) and coupled to Cyanogen
bromide-activated Sepharose 4B (CNBr-Sepharose) as
recommended by Pharmacia Fine Chemicals (Sweden). The
excess reactive sites were blocked by blocking buffer (0.1 M
glycine-HCl, pH 9.0). The prepared gels were equilibrated
with 20 mM phosphate-buffer (PB), pH 7.4, prior to use.
Larval antigens of B. annulatus were equilibrated with
equilibrating buffer and loaded on the CNBr-Sepharose
coupled to the IgGs column at a flow rate of 20 ml/h. The
unbound proteins were washed with the equilibration buffer
at a flow rate of 30 ml/h. The bound proteins were eluted
with 0.1 M glycine-HCl, pH 2.5, into Tris-base in order to
restore the pH to 7.2. The eluted proteins were dialyzed
against 20 mM Tris-HCl, pH 7.4, and 0.5 M NaCl, and were
designated as affinity-purified larval antigen of B. annulatus
(aff-LBAg).
Concanavalin A (ConA) affinity chromatography
Glycoproteins (GLPs) were isolated using a ConA-
Sepharose column according to the instructions of the
manufacturer. The eluted GLPs were equilibrated with 20
mM PB, pH 7.4, concentrated with sucrose, and designated
as larval GLPs of B. annulatus. The protein content of the
GLPs was estimated by the Bradford method [3].
SDS-PAGE
Electrophoretic analysis was performed in the Mini-
Protean II Dual-Slab Cell (BioRad, USA). Preparation of
gels, samples, and electrophoresis was performed according
to the conditions described by Laemmli [13].
Immunoblotting
Immunoblot analysis was performed using a NovaBlot
semi-dry blotter (LKB, Sweden). Preparation of buffers,
samples, and the transfer procedure was carried out according
to the method of Towbin et al. [24] with slight modifications.
Analytical isoelectric focusing
The electrophoretic analysis was performed in the
MultiphorII unit (Pharmacia, Sweden) connected to a
thermostatic circulator, and the temperature was set in the
range of 4-6
oC. Preparation of gels, samples, and
electrophoresis was performed according to the method
described by Garfin [8] with minor modifications. The gels
were stained using the silver stain method according to
Rabilloud et al. [19].
Edman degradation
The N-terminal sequences of glycoproteins were determined
by automatic Edman degradation using a liquid chromatograph
sequencer (Series 1090; Hewlett Packard, USA).Purification and characterization of two larval glycoproteins from the cattle tick,  Boophilus annulatus 177
Protein determination
Protein concentrations were determined according to the
method of Bradford [3], using bovine serum albumin as
standard protein.
Results
Purification of rabbit anti-larval antigens IgGs
The IgGs of rabbit anti-larval antigens were purified using
protein G-Sepharose. The rabbit serum was divided into
unbound proteins and bound proteins, which were mainly
anti-larval IgGs (Fig. 1).
Purification of larval immunogens
The purified IgGs were coupled to Cyanogen bromide-
activated Sepharose 4B (CNBr-Sepharose) and used to
purify the larval immunogens. Twelve mg of total larval
proteins used for immunization were loaded on the CNBr-
IgG column. The chromatographic profile of larval antigens
on the CNBr-Sepharose coupled to IgGs shows the
separation of larval antigens into unbound proteins and
bound immunogens (Fig. 2). The total yield of larval bound
immunogens was 2.5 mg, which represents around 20.8% of
the total larval proteins.
Purification of larval glycoproteins using ConA-
Sepharose
The larval immunogens (2.5 mg) were further purified by
ConA-Sepharose to purify the larval glycoproteins, which
were eluted with 0.2 M methyl α-D glucopyrinoside (Fig.
3). The total amount of larval glycoproteins eluted was
0.625 mg.
Characterization of the larval glycoproteins
The electrophoretic separation of the larval proteins shows
several proteins of high and low molecular weights, while
the electrophoretic pattern of the larval glycoproteins shows
two major protein bands at molecular weights of approximately
32 and 15 kDa (Fig. 4). The larval antigens and the isolated
larval glycoproteins were subjected to an analytical
isoelectrofocusing technique using a wide range (3.5-10) of
ampholine. The larval antigens were separated into several
proteins of different isoelectric points (pI; between 4.5 and
7.0), while the isolated larval glycoproteins were focused
between pI 6.8 and 7.2 (Fig. 5).
Fig. 1. Affinity chromatography of rabbit anti-larval antigens o n
a protein G-Sepharose column (1.6 × 4 cm). Three ml of antiser a
was applied to a column equilibrated and washed with 20 mM
PB, pH 7.4, and the bound proteins were eluted with 0.1 M
glycine-HCl, pH 2.5, at a flow rate of 60 ml/h.
Fig. 3. Affinity chromatography of larval immunogens on a Con-
A Sepharose column (1.6 × 4 cm). The unbound proteins were
washed out using 20 mM Tris-HCl, 0.5 M NaCl, pH 7.4, and the
bound glycoproteins were eluted with 0.2 M methyl α-D
glucopyrinoside at a flow rate of 30 ml/h.
Fig. 2. Affinity chromatography of whole larval antigens on
CNBr-activated Sepharose coupled to IgG from rabbit anti-
whole larval proteins (1.6 × 5 cm). The unbound proteins were
washed out using 20 mM PB, pH 7.4,  and the bound
immunogens were eluted using 0.1 M glycine HCl buffer, pH
2.5, at a flow rate of 48 ml/h.178 Amr E. El Hakim et al.
Immunoblot analysis of the purified larval glycoproteins
Previously prepared antisera separated from the blood
samples of rabbit anti-whole tick, whole larval, and gut
proteins were used to determine their reactivity with whole
larval antigens and the isolated larval GLPs in immunoblots
(Fig. 6). The figure shows two protein bands with molecular
weights of approximately 32 and 15 kDa, corresponding to
the larval GLPs (Fig. 6). The results revealed that the
antisera raised against the whole larval, whole tick, and gut
antigens contains specific antibodies against these larval
GLPs. The reaction of Con-A protein (as a control) with the
rabbit anti-larval antigens shows no reactivity of the Con-A
protein subunits with this antisera (Fig. 6).
Amino acid sequences of GLPII
The sequence of the first ten residues of the N-terminal
amino acid sequences of the 15 kDa GLP was AVDFVTVAVP.
This sequence was compared to the protein data bank, and
the BLAST analysis revealed 60% and 55% homology with
the integral membrane protein 2B from both rat and chicken,
respectively (Fig. 7).
Fig. 4. Electrophoretic pattern of the larval GLPs in 14% SDS-
PAGE. Lane 1; molecular weight markers, Lane 2; larval GLPs,
Lane 3; whole larval proteins. The gel was stained with 0.1%
Coomassie blue R-250 in the fixative solution [methanol/acetic
acid/water (45 : 10 : 45)] for 1 h, and was then destained by
repeated soaking in the fixative.
Fig. 5. Analytical isoelectrofocusing (3.5-10) of larval antigens
and isolated larval GLPs. Lane 1; whole larval antigens, Lane 2;
larval GLPs.
Fig. 6. Immunoblotting of 14% SDS-PAGE. Lane 1; Con A
against rabbit anti-whole larval proteins, Lane 2; larval GLPs
against rabbit anti-gut proteins, Lane 3; larval GLPs agains t
rabbit anti-whole larval proteins, Lane 4; larval GLPs agains t
rabbit anti-whole tick proteins, Lane 5; whole larval proteins
against normal rabbit serum, Lane 6; whole larval proteins
against rabbit anti-whole larval proteins.
Boophilus annulatus 001A V D F V T V A V P 010
Rattus norvegicus 126 AVEFISVPVP 135
Gallus gallus 122 -VEFISVPVP 130
Fig. 7. Amino acid comparison of the N-terminal sequence of the
B. annulatus larval GLPII (15 kDa) and the most significant
similar sequences in the protein data bank; the integral membrane
protein 2B from Rattus norvegicus (Accession number: Q5XIE8)
and Gallus gallus (Accession number: O42204).Purification and characterization of two larval glycoproteins from the cattle tick,  Boophilus annulatus 179
Discussion
In concert with the principles of sustainable agriculture,
vaccines offer a number of advantages over conventional
acaricides/insecticides for the control of arthropod pests.
The effect of immunization can be long-lasting and may not
include the complications of residues. Vaccines are
environmentally-safe, and arthropod resistance to vaccines
is less likely to occur than resistance to other treatments
[25,26].
The idea of developing immunoprophylactic measures
against multi-tick infestations on crossbred animals was
based on the concept that ticks feeding on appropriately
immunized hosts might ingest antibodies specific for a
target antigen(s) within the tick, producing a deleterious
effect on their feeding and reproductive performances
[2,18]. A few years ago, vaccines containing the recombinant
B. microplus gut cell surface antigen, Bm86, were
developed [27]. However, B. microplus isolates showing
low susceptibility to vaccination with Bm86 appeared [7].
The presence of Bm86-sensitive and -resistant B. microplus
strains was thought to result from sequence variations at the
B. microplus Bm86 locus. However, sequence variations at
the Bm86 locus, among other factors, could affect the
effectiveness of Bm86-containing vaccines. All such vaccines
on the market target the B. microplus species, which is
mainly a problem in Australia and in the Caribbean.
The immunoaffinity chromatographic purification method
was previously attempted for the purification of salivary
gland antigens of Amblyomma americanum [4], larval
antigens [9,10,12], gut origin larval antigen [6], and nymphal
antigen [22] of Hyalomma anatolicum. In the case of B.
microplus, 3 antigens with molecular weights of 86 kDa
[20], 63 kDa [15], and 75-80 kDa [7] were isolated in pure
form and tested for their protective potentiality. The
presently isolated larval glycoproteins of comparatively
lower molecular weights of 32 kDa and 15 kDa may enrich
the list of purified tick antigens. These B. annulatus larval
glycoproteins will be further characterized, and will be
tested for their protective efficacies.
The most important factors on which the success of
immunoprotective measure stands are the antigenic dose
and its combination with specific adjuvants [23]. Willadsen
et al. [29] described two doses of 9.2 and 17.0 µg of 89 kDa
glycoprotein per animal in two separate experiments, and
used this formulation successfully against B. microplus
challenge infestations. The other Australian scientists used
500 µg affinity-purified larval antigens per animal [30]. In
the case of H. anatolicum, 2 mg of larval origin 39 kDa
protein [9,10], 1.6 mg of gut origin larval antigens [6], and
1.6 mg of nymphal origin of 39 kDa protein [22] were used
and found to be protective against homologous challenge.
In the present investigation, a biochemical approach has
been adopted to achieve the main goal of vaccine production
against B. annulatus. Two specific larval glycoproteins were
isolated by two-step affinity chromatography. These
glycoproteins have molecular weights of approximately 32
and 15 kDa with isoelectric points between 6.8 and 7.2.
These two GLPs reacted with the rabbit antisera against
whole tick, whole larval, and gut antigens, which demonstrates
that these GLPs have specific antibodies in these antisera.
These results suggest that these GLPs may be good
immunogens, and can be useful in the vaccination of cattle
against cattle tick infestation. The immunogenicity of these
proteins could be a result of their positions as membrane
proteins. The reaction of these GLPs with the hyperimmune
sera from rabbits would confirm the fact that unfed larvae
provides an easier source of biological material for the
isolation of protective antigens, and is consistent with the
data collected by Ghosh et al. [10,11] and Ghosh and Khan
[9].
However, the sequence of the first ten residues of the N-
terminal amino acid sequence of the 15 kDa GLPII was a
small sequence, and the protein-protein BLAST showed a
significant similarity with the integral membrane protein 2B
from  Rattus norvegicus (60%) and Gallus gallus (55%).
This integral protein is a glycosylated transmembrane
protein with only one potential glycosylation site. More
trials will be carried out to complete the sequence of this
molecule, which may allow us to determine its structure,
modifications, and possible role in the vaccination of cattle
against B. annulatus infestations.
These studies may facilitate the use of an mRNA isolation
procedure, leading to the application of recombinant DNA
technology and in vitro expression of this protein.
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